• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

Aphria Commends UK Government on Medical Cannabis Legalization, Forms Alliance With Noted Neurologist and Leading Cannabis Advocate Professor Michael Barnes

October 17, 2018 by Emerald Media Group Leave a Comment

This information was provided by prnewswire

Send your Press Release here.

The Company and Professor Barnes will collaborate on clinical trials to advance the applications of medical cannabis

LEAMINGTON, ON, Oct. 16, 2018 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH and US OTC: APHQF) commends the Government of the United Kingdom for its decision last week to legalize medical cannabis. The Company is pleased to also announce that is has formed an alliance with noted UK-based neurologist and rehabilitation physician Professor Michael Barnes MD FRCP, a leading voice on medical cannabis policy in Europe.

 

“I applaud the UK government for taking this step to legalize medical cannabis,” said Vic Neufeld, Chief Executive Officer of Aphria. “It’s great news for patients in need across the UK and represents another major milestone in the advancement of medical cannabis around the world. We are also thrilled to join forces with Professor Barnes, among the world’s most respected and influential advocates for medical cannabis.”

Professor Barnes is a celebrated authority on neurological rehabilitation in the UK and internationally. He has a long-standing interest and expertise in the use of cannabinoids for the management of spasticity and in other neurological conditions. He was involved with the development of GW Pharma’s Sativex and provided the final expert independent opinion to the UK government prior to license approval. His review of cannabis medical indications for the all-party parliamentary group on drug reform was highly influential in the UK Government’s decision to legalize cannabis for medicinal purposes.

“This is a tremendous moment for medical cannabis in the UK and its momentum towards continued acceptance and application around the world,” said Professor Barnes. “I have long been interested in the medical applications of cannabis, and I look forward to a fruitful collaboration with Aphria, one of the leading global cannabis companies, to further the exploration of medical cannabis through clinical examination.”

Professor Barnes is an honorary professor of neurological rehabilitation at the University of Newcastle, Founder President of the World Federation of Neurological Rehabilitation and Past President of the British Society of Rehabilitation Medicine. He has also served as chief executive of NHS organizations.

Aphria and Professor Barnes are collaborating on clinical studies of patients in the UK and Canada to advance the understanding of the application of medical cannabis to certain conditions and disease states.

We Have A Good Thing Growing

Filed Under: Press Release Tagged With: Press

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Subscribe to Emerald's Newsletter

loader

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Are Pre-Rolls the Future of Cannabis Retail?
  • Oxalis Integrative Support Services
  • Unlocking the Future of Cannabis Consumption: Amedicanna’s Nano Emulsified Beverages
  • From Veterans to Entrepreneurs: How Emanuel Ledezma, Rudy Rendon, and Erwin Sibal Became Leaders in the Cannabis Industry 
  • Cannifest 2023

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.